Lawrence Delevingne is the 'Big Money' enterprise reporter for CNBC.com in New York. He focuses on large money managers, especially hedge and private equity funds.
Before joining CNBC in September 2013, Delevingne was a senior staff writer at hedge fund publication Absolute Return from 2010 to 2013. He has also written for Business Insider, Fortune and BusinessWeek.
Prior to journalism, Delevingne worked in communications, specializing in corporate responsibility at Burson-Marsteller in Washington. He holds a Master's degree from Columbia University's Graduate School of Journalism and a Bachelor's degree from Georgetown University's School of Foreign Service. At Georgetown, he studied international affairs with a focus on Africa.
Follow Lawrence Delevingne on Twitter at @ldelevingne
Or email him at email@example.com
His days start at 5:15 a.m. and end at 11 p.m. But the long hours more than pay off for Leon Cooperman, the billionaire founder of Omega Advisors.
Billionaire investor John Paulson is looking to make more money on health care.
There's now more data to support the idea that doing well and doing good are not mutually exclusive.
Becton Dickinson will pay $24 billion in cash and stock to buy CR Bard.
A love of cars and a willingness to 'run to the fire' helped Mark Fields rapidly ascend through the ranks at Ford.
Emmanuel Macron and Marine Le Pen will face one another in the final round of the French presidential election on May 7.
Guy Look, CFO of Sa Sa International, explains why Hong Kong's tourism market is losing global competitiveness.
Richard Peretz, CFO of UPS, discusses the international considerations of doing business in the light of the current political rhetoric on trade, as well as the company's push to continue to be the preferred shipper for e-commerce.
Results from CNBC's CFO Council Survey show 66.7 percent of chief financial officers thought Donald Trump would win the Republican nomination for president.
Take an in-depth look at the world of modern medicine - examining the treatments, companies and people making a difference in the way we treat illness and injuries today, and laying the foundation for the medical treatments of tomorrow.
Using ETFs investors can now span the globe in their portfolios. It’s now more important than ever to diversify assets.
Where headlines become opportunities.